Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05343598 · ClinicalTrials.gov registry record · NA

Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

A NA study of Schizophrenia and Schizo Affective Disorder, sponsored by Mclean Hospital.

Recruiting
Registry status
NA
Development phase
68
Enrollment target
1
Study location

NCT05343598 is a NA study of Schizophrenia and Schizo Affective Disorder that is actively recruiting participants, run by Mclean Hospital. The registered enrollment target is 68 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05343598, a NA study of Schizophrenia and Schizo Affective Disorder, is actively recruiting participants, sponsored by Mclean Hospital.

RECRUITING
Registry status
NA
Development phase
68 participants
Enrollment target
1
Study location

Study Summary

This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study how hallucinations work in schizophrenia. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study the investigators will be stimulating the brain to learn more about how TMS might improve these symptoms of schizophrenia.

Conditions Studied

Schizophrenia Schizo Affective Disorder

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)
  • DEVICE Sham Repetitive Transcranial Magnetic Stimulation (rTMS)

Study Locations (1)

Massachusetts

  • McLean Hospital - Belmont

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2021-10-13
Est. Completion 2026-10-31
Phase NA

Sponsor

Mclean Hospital

140 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05343598

The ClinicalTrials.gov registry entry for NCT05343598 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (69% lower). The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.

NCT05343598 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05343598 about?

NCT05343598 is a clinical study titled "Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia". This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study how hallucinations work in schizophrenia. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held ...

What is the current status of trial NCT05343598?

This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2021-10-13. Estimated completion is 2026-10-31.

What conditions does trial NCT05343598 study?

This clinical trial studies the following conditions: Schizophrenia, Schizo Affective Disorder.

What interventions are being tested in trial NCT05343598?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE), Sham Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE).

Who is sponsoring clinical trial NCT05343598?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05343598 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

Schizo Affective Disorder

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.